Rochester, NY 8/31/2009 5:41:03 PM
DAP TMS SA EDAP, last trade hit $3.88 at End Session
DAP TMS SA EDAP
DAP TMS SA release its trading hit 16 cents or 3.96% to $3.88 at closed market. It hits a 52-week low of 0.96 and a 52-week high of 5.95. The company posted volume of $498,824 shares.
The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of certain types of localized tumors using HIFU technology. The HIFU technology enables the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 3.88
Day's Range: 3.82 - 4.30
52wk Range: 0.96 - 5.95
Change: 0.00 (0.00%)
Volume: 0
Avg Vol (3m): 498,824
ABOUT EDAP TMS S.A.
EDAP TMS S.A. and its subsidiaries develop, produce, market, distribute, and maintain medical devices for the treatment of urological diseases. It operates in two divisions, High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of certain types of localized tumors using HIFU technology. The HIFU technology enables the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. It offers Ablatherm, a HIFU-based device for the treatment of organ-confined prostate cancer. The UDS division produces and markets medical devices, known as lithotripters, for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones, and other clinical indications using ESWL technology. It manufactures three models of lithotripters: the Sonolith Praktis, the Sonolith Vision, and the Sonolith I-Sys. This division also involves in leasing lithotripters, as well as offers disposables, spare parts, and maintenance services. It serves hospitals, urology clinics, and research institutions. The company markets and sells its products through its direct marketing, service platform, and sales organization, as well as through third-party distributors and agents worldwide. EDAP TMS S.A. has a research co-operation with the French National Institute for Health and Medical Research to develop its ESWL technology. The company was founded in 1979 and is based in Vaulx-en-Velin, France.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
